The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease

Basit Öğe Kaydı
dc.authorid0000-0002-8618-6402
dc.authorid0000-0001-8145-1900
dc.authorid0000-0003-2215-9410
dc.authorid0009-0005-4157-0426
dc.authorid0000-0002-6202-0993
dc.authorid0000-0001-7634-0843
dc.authorid0000-0002-8909-2102
dc.authorid0000-0002-0544-5610
dc.contributor.authorEslam, Mohammed
dc.contributor.authorFan, Jian-Gao
dc.contributor.authorYu, Ming-Lung
dc.contributor.authorWong, Vincent Wai-Sun
dc.contributor.authorCua, Ian Homer
dc.contributor.authorLiu, Chun-Jen
dc.contributor.authorTanwandee, Tawesak
dc.contributor.authorÖrmeci, Necati
dc.contributor.authorK. Sarin, Shiv
dc.contributor.authorGeorge, Jacob
dc.date.accessioned2025-03-11T08:13:44Z
dc.date.available2025-03-11T08:13:44Z
dc.date.issued2025
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractMetabolic dysfunction-associated fatty liver disease (MAFLD) affects over one-fourth of the global adult population and is the leading cause of liver disease worldwide. To address this, the Asian Pacific Association for the Study of the Liver (APASL) has created clinical practice guidelines focused on MAFLD. The guidelines cover various aspects of the disease, such as its epidemiology, diagnosis, screening, assessment, and treatment. The guidelines aim to advance clinical practice, knowledge, and research on MAFLD, particularly in special groups. The guidelines are designed to advance clinical practice, to provide evidence-based recommendations to assist healthcare stakeholders in decision-making and to improve patient care and disease awareness. The guidelines take into account the burden of clinical management for the healthcare sector.
dc.identifier.citationEslam, M., Fan, J. G., Yu, M. L., Wong, V. W. S., Cua, I. H., Liu, C. J., Tanwandee, T., Örmeci, N., Sarin, S. K., & George, J. (2025). The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease. Hepatology International, https://doi.org/10.1007/s12072-024-10774-3
dc.identifier.doi10.1007/s12072-024-10774-3
dc.identifier.issn1936-0541
dc.identifier.issn1936-0533
dc.identifier.pmid40016576
dc.identifier.urihttps://doi.org/10.1007/s12072-024-10774-3
dc.identifier.urihttps://hdl.handle.net/20.500.13055/932
dc.identifier.wosWOS:001434325100001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynak.otherSCI-E - Science Citation Index Expanded
dc.institutionauthorÖrmeci, Necati
dc.institutionauthorid0000-0002-8909-2102
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofHepatology International
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleThe Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
1.79 MB
Biçim:
Adobe Portable Document Format
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu